We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+6.08%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$42.8B
AUM Growth
+$3.35B
Cap. Flow
+$1.35B
Cap. Flow %
3.15%
Top 10 Hldgs %
14.82%
Holding
2,894
New
39
Increased
2,631
Reduced
168
Closed
44

Top Buys

Rank Stock Value
1
ABT icon
Abbott
ABT
+$21.8M
2
CVX icon
Chevron
CVX
+$20.5M
3
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$19.7M
4
INCY icon
Incyte
INCY
+$17.8M
5
XOM icon
ExxonMobil
XOM
+$16.9M

Sector Composition

Rank Sector Weight
1 Financials 16.2%
2 Technology 15.06%
3 Healthcare 13.05%
4 Industrials 10.88%
5 Consumer Discretionary 9.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PBPB
2426
DELISTED
Potbelly
PBPB
$351K ﹤0.01%
25,271
+880
+4% +$11.6K
FRPH icon
2427
FRP Holdings
FRPH
$430M
$350K ﹤0.01%
17,508
+588
+3% +$11.5K
ACRS icon
2428
Aclaris Therapeutics
ACRS
$715M
$349K ﹤0.01%
11,687
+1,555
+15% +$44.8K
NKSH icon
2429
National Bankshares
NKSH
$254M
$349K ﹤0.01%
9,304
+237
+3% +$9.61K
CRIS icon
2430
Curis
CRIS
$9.61M
$348K ﹤0.01%
63
+3
+5% +$16.7K
OXFD
2431
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$348K ﹤0.01%
22,447
+1,074
+5% +$15.3K
EMCI
2432
DELISTED
EMC INS Group Inc
EMCI
$347K ﹤0.01%
12,359
+392
+3% +$11.3K
ACBI
2433
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
$346K ﹤0.01%
18,264
+713
+4% +$13.5K
RT
2434
DELISTED
Ruby Tuesday Georgia
RT
$346K ﹤0.01%
123,073
+31,180
+34% +$67.9K
HOV icon
2435
Hovnanian Enterprises
HOV
$727M
$345K ﹤0.01%
6,071
+206
+4% +$12.2K
HURC icon
2436
Hurco Companies Inc
HURC
$137M
$345K ﹤0.01%
11,096
-327
-3% -$9.71K
PFIS icon
2437
Peoples Financial Services
PFIS
$684M
$343K ﹤0.01%
8,214
+298
+4% +$13K
RAS
2438
DELISTED
RAIT Financial Trust
RAS
$343K ﹤0.01%
107,048
+3,728
+4% +$12.7K
OTIC
2439
DELISTED
Otonomy, Inc.
OTIC
$341K ﹤0.01%
27,857
+818
+3% +$11.9K
ADMS
2440
DELISTED
Adamas Pharmaceuticals
ADMS
$341K ﹤0.01%
19,472
+1,619
+9% +$27.6K
GNBC
2441
DELISTED
Green Bancorp, Inc
GNBC
$341K ﹤0.01%
19,152
+870
+5% +$14.1K
BATRA icon
2442
Atlanta Braves Holdings Series A
BATRA
$3.45B
$340K ﹤0.01%
14,208
+1,273
+10% +$27.2K
RMTI icon
2443
Rockwell Medical
RMTI
$28.6M
$340K ﹤0.01%
493
+15
+3% +$9.88K
BSTC
2444
DELISTED
BioSpecifics Technologies Corp.
BSTC
$340K ﹤0.01%
6,201
+412
+7% +$21.8K
SPNS
2445
DELISTED
Sapiens International
SPNS
$339K ﹤0.01%
26,346
+799
+3% +$11K
ARTNA icon
2446
Artesian Resources
ARTNA
$352M
$337K ﹤0.01%
10,355
+267
+3% +$8.5K
VIVS
2447
VivoSim Labs
VIVS
$1.25M
$336K ﹤0.01%
441
+49
+13% +$38.8K
MRLN
2448
DELISTED
Marlin Business Services Corp
MRLN
$336K ﹤0.01%
13,056
+541
+4% +$12.7K
FARM
2449
DELISTED
Farmer Brothers
FARM
$335K ﹤0.01%
9,466
+206
+2% +$6.93K
ADXS
2450
DELISTED
Advaxis Inc
ADXS
$335K ﹤0.01%
2,732
+89
+3% +$11.6K

Similar funds

RhumbLine Advisers's Q1 2017 Portfolio in Review

As of Q1 2017, RhumbLine Advisers held 2,894 positions worth $42.8B, up 8.5% from $39.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

RhumbLine Advisers deployed $1.35B of net new capital in Q1 2017, opening 39 new positions and adding to 2,631 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Biogen, an estimated $8.21M trimmed.

  • RhumbLine Advisers's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
  • RhumbLine Advisers added most to Abbott in Q1 2017, an estimated $21.8M increase.
  • RhumbLine Advisers's biggest Q1 2017 reduction was Biogen, cutting an estimated $8.21M.
  • RhumbLine Advisers fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $49.6M.
  • RhumbLine Advisers's ten largest holdings make up 15% of its $42.8B portfolio in Q1 2017.
  • RhumbLine Advisers opened 39 new positions and closed 44 in Q1 2017.
  • RhumbLine Advisers's portfolio value rose 8.5% quarter-over-quarter to $42.8B.

Based on RhumbLine Advisers's 13F filing for Q1 2017, filed 2 May 2017.